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Abstract
While  RNA sequencing (RNA‐seq)  has become increasingly popular  for  transcrip‐
tome profiling, the analysis of the massive amount of data generated by large‐scale
RNA‐seq still  remains  a  challenge.  RNA‐seq data  analyses  typically  consist  of  (1)
accurate mapping of millions of short sequencing reads to a reference genome, including
the  identification  of  splicing  events;  (2)  quantifying  expression  levels  of  genes,
transcripts,  and exons;  (3)  differential  analysis of  gene expression among different
biological conditions; and (4) biological interpretation of differentially expressed genes.
Despite  the  fact  that  multiple  algorithms  pertinent  to  basic  analyses  have  been
developed, there are still a variety of unresolved questions. In this chapter, we review
the main tools and algorithms currently available for RNA‐seq data analyses, and our
goal is to help RNA‐seq data analysts to make an informed choice of tools in practical
RNA‐seq data analysis.  In the meantime, RNA‐seq is evolving rapidly, and newer
sequencing technologies are briefly introduced, including stranded RNA‐seq, targeted
RNA‐seq, and single‐cell RNA‐seq.
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1. Introduction
In  recent  years,  RNA sequencing (RNA‐seq)  has  emerged as  a  powerful  technology for
transcriptome profiling [1–4]. Compared with microarrays, it not only avoids some of the
technical limitations of this approach including varying probe performance and nonspecific
hybridization, and dynamic range issues, but can also detect alternative splicing isoforms and
subtle changes of  splicing under different conditions.  The overview of  current RNA‐seq
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
approaches using shotgun sequencing technologies such as Illumina and the corresponding
data analysis workflow is summarized in Figure 1. Polyadenylated (Poly‐A) RNA transcripts
(for the so‐called mRNA‐seq) are enriched with oligo (dT) primers and then fragmented. After
size selection, millions or even billions of short sequence reads are generated from a random‐
ly fragmented cDNA library. For most RNA‐seq studies, the data analyses consist of the following
key steps [5, 6]: (1) quality check and preprocessing of raw sequence reads, (2) mapping reads
to a reference genome or transcriptome, (3) counting reads mapped to individual genes or
transcripts, (4) identification of differential expression (DE) genes between different biologi‐
cal conditions, and (5) biological interpretation of DE genes and functional enrichment analysis.
Despite the fact that a large number of algorithms [7] have been developed for RNA‐seq data
analysis in recent years, there are still many open questions for accurate read mapping, gene
quantification, and data normalization.
Figure 1. Overview of mRNA‐seq laboratory flowchart and data analysis pipeline.
In complex mammalian genomes, both DNA strands encode genes. As a result, if two genes
transcribed from opposite strands overlap, nonstranded RNA‐seq cannot tell the true origin
if a read falls into overlapping regions. Most recently, a stranded RNA‐seq protocol has been
developed for more accurate gene quantification [8, 9]. RNA‐seq is a powerful tool when used
to profile the entire transcriptome. However, this method can be inefficient when interested
in only a small subset of genes that are involved in particular pathways, or associated with
specific diseases. To meet this demand, targeted RNA‐seq technology has been developed.
Traditionally, gene expression measurements were performed on “bulk” samples containing
populations of thousands or millions of cells. Recent advances in genomic technologies have
made it possible to measure gene expression in individual cells. Accordingly, cellular prop‐
erties that were previously masked in “bulk” measurements can now be observed directly [10–
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12]. Single‐cell RNA‐seq (scRNA‐seq) introduces more challenges for data analyses due to
technical noise, including coverage nonuniformity, data sparsity, amplification biases, and so
on. In this chapter, we cover the topics related to RNA‐seq technology and data analyses.
2. RNA‐seq versus microarray for gene expression profiling analysis
Microarrays and RNA‐seq have been the two technologies of choice for large‐scale studies of
gene expression, and the side‐by‐side comparisons of RNA‐seq and hybridization‐based
arrays have been performed [12–15]. Malone et al. [16] compared its ability to identify
differentially expressed genes with existing array technologies and found that RNA‐seq data
are highly reproducible with relatively little technical variation. The DE genes identified from
RNA‐seq had a high overlapping with those identified by microarray. Fu et al. [17] designed
a study in which they evaluated the accuracy of both microarrays and RNA‐seq for mRNA
quantification by using protein expression measurements as ground truths. In that study, they
assessed the relative accuracy of the two transcriptome quantification approaches with respect
to absolute transcript level measurements and found that RNA‐seq provides better estimates
of transcript expressions.
Previously, we performed a side‐by‐side comparison of RNA‐seq and microarrays in investi‐
gating T‐cell activation [18]. A comparison of data sets derived from RNA‐seq and Affymetrix
platforms using the same set of samples revealed a very high concordance between expression
profiles generated by the two platforms. In the meantime, it was also demonstrated that RNA‐
seq is superior in differentiating biologically critical isoforms, detecting low abundance
transcripts, and allowing the identification of genetic variants. Analysis of the two data sets
also showed the benefit derived from avoidance of technical issues inherent to microarray
probe performance such as cross‐hybridization, nonspecific hybridization, and limited
detection range of individual probes. In addition, RNA‐seq has a much broader dynamic range
than microarray technologies, which allows for the detection of more differentially expressed
genes with higher fold‐change. Thus, RNA‐seq delivers both less biased and previously
unknown information about the transcriptome. Because RNA‐seq does not rely on a prede‐
signed complementary sequence detection probe, it is not limited to the interrogation of
selected probes on an array and can also be applied in species, for which the whole reference
genome is not yet assembled.
RNA‐seq allows for the detection of novel transcript species in well‐studied organisms, such
as unique transcripts in certain tissues or in rare cell types, and has been instrumental to catalog
the diversity of novel transcript species including long noncoding RNA, miRNA, siRNA, and
other small RNA classes [19]. Additionally, RNA‐seq technology proves to be an invaluable
tool for deciphering the extensive alternative splicing of the transcriptome [20, 21]. Alternative
splicing creates two to potentially hundreds of variants in more than 90% of human genes.
Furthermore, RNA‐seq can identify allele‐specific expression and gene fusion events [22, 23].
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3. RNA‐seq library preparation and sequencing platforms
3.1. General considerations for RNA‐seq
The quality and quantity of the starting RNA material are likely the most important aspects
to consider when deciding on the methods to generate RNA‐seq libraries. For high‐quality
samples with mostly intact RNA, a wide variety of sequencing library preparation methods is
available. For lower quality samples with partially or highly degraded RNA, there are
considerably fewer methods to choose from. The amount of RNA may limit the choice of library
preparation as well, since the majority of standard RNA‐seq kits require a minimum of 10–100
ng of the total RNA. If the RNA amount is below this threshold it will require the use of a more
specialized kit and/or the sample may require some form of amplification.
To obtain reliable and reproducible RNA‐seq data, RNA quality is of paramount importance.
Because of the inherent instability of the RNA molecule, the quality of RNA from samples
collected in clinical settings and field studies is often impacted by tissue necrosis, which quickly
degrades RNA if the sample is not frozen or chemically preserved within minutes after surgery.
For assessing RNA quality, most labs utilize an electrophoretic‐based system, including the
Agilent BioAnalyzer, the Agilent TapeStation, or the Advanced Analytics Fragment Analyzer.
All of these instruments produce an RNA integrity score. On the BioAnalyzer, the score ranges
from 1 to 10 (10 being perfect) and most labs would consider a RIN > 6 to be acceptable for
standard RNA‐seq methods. For degraded samples where the RIN is below 6, it is beneficial
to calculate the DV200 score (the percent of the sample that is larger than 200 bp in size).
Illumina has shown this to be an important metric for successful library preparation with kits
designed for degraded RNA.
After quality and quantity of the RNA samples have been addressed, one must then choose
whether to profile the total RNA space or the mRNA space only. This choice determines the
main split between most RNA‐seq library kit types, those which target the removal of
ribosomal RNA (rRNA) versus those which utilize Poly‐T beads to isolate the Poly‐A tail of
intact mRNAs. This choice will affect the downstream sequencing, influencing the depth to be
targeted per sample, with rRNA depletion libraries requiring significantly deeper sequencing
than Poly‐A‐based libraries in order to generate sufficient reads to capture all of the different
RNA species in these samples. Additionally, if you are dealing with degraded RNA samples,
you will not be able to utilize the Poly‐A method, but the rRNA depletion methodologies will
work for these samples. However, if you still want to focus only on the mRNAs, another option
would be the more recent exon capture kits such as Illuminas RNA Access, which depend on
hybridization with probes designed against known exons.
When considering the sequencing depth, a few considerations should be taken into account.
mRNA libraries can be sequenced shallower than the total RNA libraries as they have less
diversity and are focused only on the mature transcripts. In general a total RNA prep will only
have 15–30% of the sample as mRNA, thus to get the same level of read depth for the mRNAs
you will need to sequence those libraries between 3 and 10× as deep as a mRNA only library.
Additionally, whether the goal of the experiment is targeted toward DE, isoform discovery,
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or novel RNA discovery will impact the choice of read depth to target, with the latter requiring
more reads. In general, targeting 30–40 million paired reads for an mRNA‐seq and 70–100
million for a total RNA‐seq would be the starting recommendation.
3.2. From RNA sample to raw sequence reads
The most common workflow for RNA‐seq is stranded mRNA‐seq. To generate a stranded
mRNA‐seq library, RNA from different sources (blood, tissue, and cell lines) should be purified
utilizing a consistent methodology (kits with columns or manually using Trizol are both
acceptable). The RNA should be treated either in solution or on‐column (depending on your
extraction choice) with DNASE to remove traces of genomic DNA and to prevent contamina‐
tion of RNA‐seq libraries by DNA. DNA‐free RNA should then be assessed for both quality
and quantity. RNA of sufficient quality can then be passed over Oligo‐dT beads to capture
mRNAs removing the non‐Poly‐A RNA species. The captured mRNA is then fragmented
(enzymatically or mechanically) through ultrasonic shearing (with devices such as a Covaris
ultrasonicator), followed by a two‐step conversion to cDNA using first‐strand synthesis and
then second‐strand synthesis (during which the cDNA is marked retaining the strand infor‐
mation) protocols. After cDNA conversion, the ends are repaired making them amenable to
adapter ligation. Indexing of the libraries can be utilized at this point allowing for sample
pooling before sequencing and a final enrichment of the indexed cDNA fragments by PCR
(Illumina recommends 10–15 cycles of PCR depending on the RNA input), which is performed
to generate the final RNA‐seq library.
After the libraries are complete, their quality is assessed by an electrophoretic assay, if a peak
at the size of dimerized adapters (80–100 bp) is observed, the libraries should be repurified
before sequencing (adapter dimers will cluster very efficiently and many reads can be lost if
they are not fully removed). The sequencing‐ready libraries are quantified to allow for
equimolar pooling typically through quantitative PCR. Method such as KAPA Library
Quantification kits are recommended for best results. After quantification, libraries with
different indices are pooled. The number of samples in the pool will vary depending on the
read depth desired and sequencer used. Sequencing is then performed on a final diluted
sample (following the manufacturer's recommendations). After the run is complete, the raw
reads can be converted to fastq files (if Illumina sequencing was performed, Illumina offers an
algorithm for this step called bcltofastq) and passed on for QC, alignment, and analysis.
4. Algorithms for RNA‐seq data analysis
Millions, or even billions, of short reads are the starting point of RNA‐seq computational data
analyses [5, 6]. First, reads are QC checked and then mapped to a reference genome or
transcriptome. The mapped reads for each sample are subsequently counted on gene, tran‐
script, or exon level to assess the abundance of each category depending on the experimental
purpose. The summarized data are then assessed by statistical models to identify differentially
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expressed genes. Finally, pathway or network level analyses are performed to gain biological
insight through systems biology approaches.
4.1. Quality check and preprocessing of raw reads
Poor‐quality read data can arise from problems in the library preparation or from sequencing
itself. Additionally, PCR artifacts, untrimmed adapter sequences, sequence‐specific bias, and
other possible contaminants can also lead to poor data quality. The presence of poor quality
or technical sequences can affect the downstream analysis and data interpretation, and thus
give inaccurate results. In order to assess quality of raw sequenced data, several tools such as
PRINSEQ [24] and FastQC [25] have been developed. FastQC aims to provide a simple way
to do some quality control checks on raw sequence data. It provides a modular set of analyses
that can be used to give a quick impression of whether raw sequencing data have any problems
that one should be aware of before doing any further analysis. Once the data are checked for
quality, they should be processed to remove reads with low‐quality bases, adapter sequences,
and other contaminating sequences. Tools such as Cutadapt [26] and Trimmomatic [27], which
trim adapter or other contaminating sequences based upon user‐provided parameters, can be
used for performing these operations. After going through the aforementioned steps, the
sequencing data are ready for downstream analysis.
4.2. Read mapping
Short sequence reads generated by sequencers must first be mapped or aligned to a reference
transcriptome or genome assembly to discover their true locations (origins) with respect to
that reference. A large number of read mapping algorithms have been developed in recent
years, including TopHat2 [28], STAR [29, 30], GSNAP [31], OSA [32], and MapSplice [33]. To
assess the performance of current mapping software, Engström et al. [34] compared 26
mapping protocols based on 11 programs and pipelines and found there were major perform‐
ance differences among different methods on numerous benchmarks, including basewise
accuracy, alignment yield, gap placement, mismatches, and exon junction sites.
Indeed, some features of a reference genome such as repetitive regions, assembly errors, and
assembly gaps render this objective impossible for a subset of reads. Furthermore, because
RNA‐seq libraries are constructed from transcribed RNA, intronic sequences are not present
in exon‐exon spanning reads. Therefore, when aligning the sequences to a reference genome,
reads that span exon‐exon junctions have to be split across potentially thousands of bases of
intronic sequence. Many RNA‐seq alignment tools use reference transcriptomes to inform the
alignment of junction reads. The benefits of using a reference transcriptome to map RNA‐seq
reads have been demonstrated clearly in previous reports [35–37] and our own comprehensive
evaluation [38] of RefGene (RefSeq Gene) [39], UCSC Known Genes [40], and Ensembl [41] in
mapping of RNA‐seq reads and gene quantifications.
The benefits of using a reference transcriptome in mapping of RNA‐seq reads are illustrated
in Figure 2. In Figure 2A, 19 junction reads can be uniquely mapped to gene HSP90AB1 when
RefGene annotation [36] is provided in the alignment step. However, four reads indicated by
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the red arrow are mapped to the same gene HSP90AB1 as nonjunction reads with mismatches
at one end without the assistance of a reference transcriptome. In Figure 2B, those exon‐exon
spanning reads are mapped to gene TCEA3 with the exact same start and end positions
regardless of the use of a transcriptome, but spliced differently. Both mappings are equal in
terms of alignment scores and gaps between exons. It is therefore difficult, if not impossible,
to tell which alignment is correct without the assistance of a reference transcriptome. Collec‐
tively, the two examples in Figure 2 illustrate the importance of appropriate gene annotations
in the correct alignment of junction reads.
Figure 2. The impact of a reference transcriptome on the mapping of junction reads. Some exon‐exon spanning reads
are mapped incorrectly without the help of a reference transcriptome. Note the reads colored in blue are mapped to
“+” strand, and in green when mapped to “-” strand. The mismatch nucleotide bases are colored in red.
Another problem in read mapping is that of polymorphisms, which occur when sequence
reads align to multiple locations of the genome, abbreviated as multireads. Polymorphisms
are especially common for large and complex transcriptomes, and the number of multireads
for a mammalian genome is estimated to be between 10 and 40% [1, 3]. Generally speaking,
there are three common strategies to deal with multireads in practice. The first strategy is to
ignore or discard them completely, which we have demonstrated is not ideal for accurate gene
quantification [36]. This practice not only discards potentially useful information, but also
introduces an underestimation bias in quantifying expression of genes with highly redundant
sequences (e.g., young duplicated genes). The second strategy implemented in most mapping
software is to randomly assign a position from the possible matches. This practice assumes a
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multiread can originate from these genomic locations equally, but this assumption is often not
valid. The third strategy is to report all mapped locations for a multiread as long as the number
of possible matches is below a user‐defined cutoff, let's say 10. The problem with this strategy
is that the cutoff is somewhat arbitrary. For an accurate detection and quantification of
transcripts, it is important to resolve the mapping ambiguity for RNA‐seq reads that can be
mapped to multiple loci [42].
4.3. Read counting and gene quantification
Since RNA‐seq has become a common technology in molecular biology laboratories, a number
of methods have been developed for the inference of gene and isoform abundance, including
RSEM [43], Cufflinks [44], IsoEM [45], featureCounts [46], and HTSeq [47]. The algorithms
featureCounts [46] and HTSeq [47] are comparable in terms of counting results, but feature‐
Counts is considerably faster than HTSeq by an order of magnitude for gene‐level summari‐
zation and requires far less compute memory. However, neither featureCounts nor HTSeq can
count reads at the transcript level due to their implementation. Andelini et al. [48] carried out
a simulation study to assess the performance of five widely used counting tools and concluded
that performance was heavily dependent upon the true abundance of the isoforms. Lowly
expressed isoforms are poorly detected regardless of the methods.
Most recently, Kanitz et al. [49] have evaluated the accuracy of 14 methods for estimating
isoform abundance and found that these tools vary widely in memory and runtime require‐
ments. The algorithms for gene quantification can be broadly divided into two categories:
transcript‐based approaches (such as RSEM [43]) and “union‐exon”‐based approaches (such
as featureCounts [46]). Because different isoforms of a gene typically have a high proportion
of genomic overlap, it is intrinsically more difficult to estimate the expression of individual
isoforms. Union‐exon‐based methods are much simpler, in which all overlapping exons of the
same gene are merged into union exons. A read is counted to the gene as long as it has sufficient
overlap with any of its union exons. Compared with isoforms, reads can be assigned to genes
with much higher confidence. Therefore, the union‐exon‐based counting method is commonly
used in RNA‐seq, though gene‐level counts cannot distinguish Isoforms [50].
A gene can be expressed in one or more transcript isoforms; accordingly, its expression level
should be represented as the sum of its isoforms. We carried out a side‐by‐side comparison
between union‐exon‐based approach and transcript‐based method in RNA‐seq gene quanti‐
fication [40], and found that gene expression levels were significantly underestimated when
the union‐exon‐based approach was used. We also discovered that the quantification of gene
expression is more accurate if gene expression levels are computed by cumulating expression
levels of transcript isoforms than by ignoring the transcript structures.
A gene model that hypothesizes the structure of transcripts produced by a gene also affects
the analysis. Among multiple genome annotation databases, RefGene, Ensembl, and the UCSC
annotation databases are the most popular. The choice of genome annotation directly affects
gene expression estimation. Recently, we systematically characterized the impact of genome
annotation on read mapping and transcriptome quantification [38]. Surprisingly, among the
21,958 common genes shared between RefGene and Ensembl annotations, only 16.3% of genes
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obtained identical quantification results. Approximately 28.1% of genes’ expression levels
differed by >5% when using different annotation, and of those, the relative expression levels
for 9.3% of genes differed by at least 50%. Our study revealed that the difference in gene
definition frequently results in inconsistency in gene quantification (Figure 3). In Ensembl, the
annotation of PIK3CA is much longer than its corresponding definition in RefGene. As a result,
much more reads are counted toward PIK3CA if Ensembl annotation is used. According to
the mapping profile of RNA‐seq reads in Figure 3, the PIK3CA gene definition in Ensembl
should be more accurate than the one in RefGene.
Figure 3. Different gene definitions for PIK3CA give rise to differences in gene quantification. PIK3CA in the Ensembl
annotation is much longer than its definition in RefGene, which explains why 1094 reads are mapped to PIK3CA in
Ensembl while only 492 reads are mapped using RefGene.
4.4. Data normalization and differential analysis
After calculating the read counts, data normalization is one of the most crucial steps of data
processing, and this process must be carefully considered, as it is essential to ensure accurate
inference of gene expression and subsequent analyses thereof. First, the sequencing depths or
library sizes (the total number of mapped reads) typically vary for different samples, which
means that the observed counts are not directly comparable between samples. The most
straightforward way of normalizing the difference in sequencing library sizes is to rescale the
total read counts. However, such normalization is quite often not enough because RNA‐seq
counts inherently represent relative abundances of genes in a sample. The number of reads
mapped to a gene is not only dependent on the expression level and length of the gene, but
also the composition of the RNA population that is being sampled. A few highly expressed
genes may consume a very large portion of the total reads in a sample, and accordingly, the
counts for all other genes are repressed. As a result, in comparison to a sample where the reads
are more evenly distributed, those repressed genes seem to have lower expression which could
give rise to a lot of falsely “differentially expressed” genes.
A fundamental research aim in many RNA‐seq studies is to identify differentially expressed
genes between distinct sample groups. Many algorithms have recently been introduced
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specifically for the identification of differentially expressed genes (DEGs) from RNA‐seq data,
including DESeq [51], edgeR [52, 53], GENE‐Counter [54], NOISeq [55], NBPSeq [56], and
Cuffdiff2 [57]. However, there is a lack of consensus on how to approach an optimal study
design and choice of suitable software for the analysis of an RNA‐seq data sets. Recently,
numerous groups [58–66] have performed a variety of comprehensive comparisons of different
statistical methods for differential RNA‐seq data analysis. Still, no general consensus has been
reached after so many head to head comparisons and evaluations.
Zhang et al. [61] evaluated the performance of three widely used software tools: DESeq, edgeR
and Cuffdiff2. They took a number of important metrics into consideration, including se‐
quencing depth and the number of replicates, and the set of identified DEGs was evaluated
with ground truths from either quantitative RT‐PCR or microarray. They concluded that no
single method is always superior in all DE analyses. It was noted that edgeR performs slightly
better than DESeq and Cuffdiff2 in terms of the ability to uncover true positives and that
Cuffdiff2 is not recommended for gene‐level DE analysis, particularly if sequencing depth is
low. Seyednasrollah et al. [65] also carried out a systematic comparison of the state‐of‐the‐art
methods in RNA‐seq differential analysis to guide the selection of a suitable package. In
general, there can be large differences between the algorithms. Similar to the evaluation
performed by Zhang et al. [63], it was observed that no single method is likely to be optimal
under all circumstances. They also demonstrated how the data analysis tool utilized can
markedly affect the outcome of a differential analysis and highlighted the importance of the
choice of software. Soneson and Delorenzi [61] have conducted extensive comparisons of 11
methods for DE analysis of RNA‐seq data and concluded that very small sample size, which
is still common in RNA‐seq experiments, imposes problems for all evaluated methods and any
results obtained under such conditions should be interpreted with caution.
We have applied edgeR to several whole blood RNA‐seq data sets (unpublished results), and
the calculated normalization factors might range from 0.4 to 1.6. We were puzzled by such an
unreasonably low or high scaling factor. The normalization method implemented in edgeR is
based on the premise that most genes are not differentially expressed. Instead of normalizing
the raw counts directly, edgeR scales the library size by a factor so that the adjusted abundance
(i.e., the ratio of read counts divided by the scaled library size) for many genes is not DE. TMM
(Trimmed Mean of M‐values) is calculated for each sample in a data set with one sample being
considered as the reference sample and the others as test samples. For each test sample, TMM
is computed between this test and the reference after exclusion of the most highly expressed
genes (5% by default) and genes with the largest fold‐changes (30% on each side of up and
down by default). Ideally, TMM should be close to 1, but in cases where it is not, its value
provides an estimate of the correction factor that must be applied to the library sizes (but not
the raw counts) for normalization. However, TMM becomes problematic when the library
composition between test and reference samples differs significantly. On the other hand,
whether the default parameters in edgeR are appropriate for a given RNA‐seq data set is
difficult to determine. Moreover, different sets of genes are used for calculation of scaling
factors across the entire data set since the genes excluded can vary from sample to sample.
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4.5. Pathway enrichment analysis
To obtain a list of DE genes is only the starting point of gaining biological insights into
experimental systems, developmental stages, or understanding of disease or molecular
mechanisms. To understand the biological context of DE genes, pathway enrichment analysis
ensues. Functional enrichment analyses rely upon annotation databases such as Gene Ontol‐
ogy (GO) [67], Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways [68], DAVID
[69], and other commercial knowledge systems such as Ingenuity Pathway Analysis (IPA).
One traditional analysis starts with a gene list of interest, identified from differential RNA‐seq
or microarray analyses, and applies statistical methods, such as the Fisher's exact test to test
for enrichment of each annotated gene set, network, and pathway.
Gene set enrichment (GSE) analysis transforms information from gene expression profiling
into a pathway summary. DE genes are quite often involved in the same biological pathways,
and GSE results offer greater biological interpretability over individual gene analysis. GSVA
[70] extends the current GSE methods to RNA‐seq data, and provides increased power to detect
subtle pathway activity changes, and constitutes a starting point to build pathway‐centric
models of system biology. SeqGSEA [71] is a new open‐source Bioconductor package for GSVA
and can detect more biologically meaningful gene sets without biases toward longer and highly
expressed genes.
Previous pathway analysis methods had been developed based on algorithms considering
pathways as simple gene lists and ignoring pathway structures. Recently methods have been
developed to incorporate various aspects of pathway topology. For example SPIA captures
pathway topology through its scoring system, in which the positions and the interactions of
the genes in the pathway are considered [72]. Accordingly, interacting DEG pairs are prefer‐
entially weighted over two noninteracting genes. Similarly, TAPPA [73] is a scoring method
in which higher weights are automatically assigned to hub genes and interacting gene pairs.
DE analysis for pathways (DEAP) [74] makes significant improvements over existing ap‐
proaches by including information about pathway topological structure. It was demonstrated
[74] DEAP identified 14 more important chronic obstructive pulmonary disease–related
pathways that existing approaches omitted.
4.6. QuickRNASeq—an integrated pipeline for efficient RNA‐seq data analysis and
interactive visualization
Although the time and cost for generating RNA‐seq data are decreasing, the analysis of
massive amounts of RNA‐seq data still remains challenging. Numerous software packages
and algorithms have been developed, which has led to the need to apply these tools efficiently
to obtain results within a reasonable timeframe, especially for large data sets. Based on our
own experience with analyses of multiple in‐house RNA‐seq data sets of varying size using
open source tools, the main challenges, gaps, and bottlenecks for large‐scale RNA‐seq data
analyses can be summarized as follows:
1. It is not trivial to select appropriate software packages and set software‐specific parame‐
ters since it requires an in‐depth understanding of the algorithms.
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2. Additional bridging scripts are often necessary to make different components work
seamlessly in a pipeline.
3. In general, most algorithms are implemented to process an individual sample, and thus
it is necessary to integrate and summarize results from individual samples.
4. Due to sample quality and the complicated multistep processes in RNA‐seq, it is required
to establish stringent RNA‐seq data quality metrics to identify outliers that should be
excluded from further downstream data analysis.
5. Nearly all RNA‐seq data analyses are performed using Linux workstations; however,
analysis results in Linux are often inaccessible to most experimental scientists. Thus,
sharing results with scientists is a practical challenge.
Figure 4. Representative entry webpage for a QuickRNAseq project report. The page layout and printable version of
the page can be controlled by the top icons. The QC Metrics section provides QC results in plain text, static plot, and
interactive plot formats accessible by clicking on the corresponding hyperlinked texts, the iconized figures, and point‐
ing hand, respectively. The parallel plot of QC offers an integrated view of linked QC measures for a single sample or a
group of samples. The expression tables section provides links to raw read counts, a normalized RPKM table, and in‐
teractive displays of gene expression levels.
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To address these challenges, we have implemented a pipeline named QuickRNASeq to
advance the automation and interactive visualizations of RNA‐seq data analysis results [75].
QuickRNASeq significantly reduces data analysts’ hands‐on time, which results in a substan‐
tial decrease in the time and effort needed for the primary analyses of RNA‐seq data before
proceeding to further downstream analysis and interpretation. Additionally, QuickRNASeq
provides a dynamic data sharing and interactive visualization environment for end users. All
the results are accessible from a web browser without the need to set up a web server and
database. The rich visualization features implemented in QuickRNASeq enable nonexpert end
users to interact easily with the RNA‐seq data analyses results and to drill down into specific
aspects to gain insights into often complex data sets simply through a point‐and‐click ap‐
proach. A representative entry webpage for a QuickRNASeq project report is shown in
Figure 4. All the result files and figures are directly accessible by “point and click” from the
entry webpage, which makes data navigation and visualization more convenient and intuitive,
especially for experimental scientists.
5. New RNA sequencing technologies
5.1. Stranded RNA‐seq
One significant shortcoming of the first‐generation RNA‐seq protocol was that it did not retain
the strand information for each transcript. Recently, strand‐specific or stranded RNA‐seq
protocols have been developed [76]. Previous reports [8] demonstrated that data from stranded
libraries are more reliable than data from nonstranded libraries and can correctly evaluate the
expression of both antisense RNA and overlapping genes. The ability to capture the relative
abundance of both sense and antisense expression provides insight into regulatory interactions
that might otherwise be missed [9]. With the ability to unlock new information on global gene
expression, stranded RNA‐seq holds the key to a deeper understanding of the transcriptome.
We performed a side‐by‐side comparison of stranded and nonstranded RNA‐seq in our whole
blood RNA‐seq data set, and demonstrated that stranded RNA‐seq provides a more accurate
estimate of gene expression compared with nonstranded RNA‐seq and is therefore the
recommended RNA‐seq approach for all future mRNA‐seq studies [77].
The advantages of stranded RNA‐seq are illustrated in Figure 5. ICAM4 (intercellular adhesion
molecule 4) shows moderate expression in whole blood. However, nonstranded RNA‐seq
reports no expression for this gene. As observed in Figure 5, ICAM4 is 100% contained within
CTD‐2369P2.8. In nonstranded RNA‐seq, a read mapped to ICAM4 is simultaneously aligned
to CTD‐2369P2.8 as well. The ambiguous reads in overlapping regions are thus excluded from
counting, which explains the lack of expression for ICAM4 with nonstranded RNA‐seq. The
ambiguous reads in overlapping genes in Figure 5 can be perfectly resolved using stranded
RNA‐seq. By considering the read direction, all reads are assigned to ICAM4 (but not CTD‐
2369P2.8), because they are all reverse complementary to ICAM4. According to a stranded
sequencing protocol, it is impossible for such reads to originate from CTD‐2369P2.8.
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Figure 5. (A) Gene expression of ICAM4 in stranded and nonstranded RNA‐seq. (B) Mapping profiles for ICAM4 (in‐
tercellular adhesion molecule 4). ICAM4 is on the “+” strand, and 100% contained within CTD‐2369P2.8 in the “-”
strand. In nonstranded RNA‐seq, the ambiguous reads in overlapping regions are excluded from counting, which ex‐
plains why there is no expression for ICAM4. However, the ambiguous reads can be perfectly resolved in stranded
RNA‐seq. By considering the read direction, all reads can be counted to ICAM4 but not CTD‐2369P2.8. Note: (1) RNAs
were extracted from pooled whole blood samples, and four replicates were pair‐end sequenced using both stranded
and nonstranded protocols. The unit of y‐axis is RPKM in the plot to the left. (2) All genes, transcripts, and sequence
reads are colored in blue if they are in the “+” strand and colored in green if in the “-” strand. According to our strand‐
ed sequencing protocol, a sequence read should be reversely complementary to its transcript origin.
5.2. Targeted RNA‐seq
RNA‐seq can be a powerful tool to measure gene expression, detect novel transcripts, charac‐
terize transcript isoforms, and identify sequence polymorphisms. However, this unbiased
RNA‐seq method can be costly and yields complex data sets that are time consuming to
analyze. Often one is interested in only a small subset of genes or the goal is to study only one
component of the transcriptome, such as long noncoding RNAs (lncRNAs), which constitute
only a small fraction of transcripts in a total RNA sample [78–80]. A targeted quantitative RNA‐
seq method that is reproducible and reduces the number of sequencing reads required to
measure key transcripts would be better suited to these purposes. Most recently, Tan et al. [80]
describes a targeted enrichment method for the analysis of lncRNAs. Targeted RNA‐seq can
measure dozens to hundreds of targets simultaneously. Targeted RNA‐seq gives an econom‐
ical way to focus on genes of interest, and provides enhanced coverage for sensitive gene
discovery, robust transcript assembly and accurate gene quantification. Common uses of this
method include:
• Profiling expression of select target genes, to assess disease‐associated variants and
epigenetic alterations.
• Analyzing gene fusions and gene expression alterations to provide a focused view of
functionally relevant changes occurring in cancer.
• Studying genes associated with a variety of key signal transduction pathways, such as NF‐
kB, P450, IFN response, apoptosis pathways, and many more.
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There are several approaches for target RNA enrichment, either by hybridization only (Agilent
SureSelect and Roche SeqCap system), hybridization followed by extension (Illumina Targeted
RNA‐seq; Figure 6) or PCR amplification (Thermo Fisher Ampliseq and BD Cellular Research
Precise Assays). Genes of interest are enriched by custom‐designed probes (Figure 6). How‐
ever, these targeted sequencing procedures can potentially introduce biases caused by
nonuniform hybridization as well as variation in amplification efficiencies across different
genes and transcripts. According to our in‐house pilot study (unpublished data), gene
expression results are very sensitive to the choice of probes and targeted regions. Cellular
Research Precise Assays [81] allow researchers to introduce so‐called unique‐sequence
barcodes into the samples to overcome possible amplification bias and thus produces more
accurate estimates of transcript abundance. By counting unique barcodes instead of reads,
researchers can determine how many copies of each transcript are expressed with very high
accuracy. In the meantime, targeted RNA‐seq poses new challenges for data analysis. For
example, most differential analysis packages assume the majority of genes are not differentially
expressed, but this assumption is most likely not valid in targeted RNA‐seq data sets.
Figure 6. TruSeq targeted RNA expression workflow. Two custom‐designed oligonucleotide probes with adapter se‐
quences hybridize up and downstream of the region of interest. ULSO stands for upstream locus‐specific oligo and
DLSO stands for downstream locus‐specific oligo.




Cell identity and function can be characterized at the molecular level by unique transcriptomic
signatures. At the organismal level, different tissues have distinct gene expression profiles,
and even cells in consecutive stages of embryonic development have highly divergent
transcriptomic landscapes. Until recently, molecular ‘fingerprints’ were generated using
profiling of gene expression levels from bulk populations of millions of input cells. These
Ensemble‐based approaches meant that the resulting expression value for each gene was an
average of its expression levels across a large population of input cells. In many contexts, such
bulk expression profiles are sufficient. However, there are also important questions for which
bulk measures of gene expression are insufficient, for instance heterogeneity in immune cells.
Besides, Ensemble measures do not provide insights into the stochastic nature of gene
expression.
Recently, RNA‐seq has achieved single‐cell resolution, and scRNA‐seq enables unbiased, high‐
throughput, and high‐resolution transcriptomic analysis of individual cells [82, 83]. This
provides an additional dimension to transcriptomic information relative to traditional
methods that profile bulk populations of cells. What is currently still missing is an effective
way to routinely isolate and process large numbers of individual cells for quantitative in‐depth
RNA‐seq. Klein et al. [84] and Macosko et al. [85] have independently developed a high‐
throughput droplet‐microfluidic approach for barcoding of RNA from thousands of individ‐
ual cells for subsequent analysis by next‐generation sequencing. Droplet‐based scRNA‐seq
will be an attractive method for many laboratories because of its seemingly unlimited scala‐
bility and relatively low cost. By combining sophisticated RNA‐seq technology with a new
device that isolates single cells and their progeny, MIT researchers can now trace detailed
family histories for several generations of cells descended from one “ancestor” [86].
Alongside the large‐scale generation of single‐cell transcriptomic data, it is important to
consider the specific computational and analytical challenges that still have to be overcome
[87]. Although some tools for bulk RNA‐seq analysis can be readily applied to single‐cell data,
many new computational strategies are required to fully exploit this new data type. For
instance, many genes at single cells are expressed in a stochastically‐bursting fashion and their
abundance exhibits a bimodal distribution in cell populations. Another main problem we face
is that each cell can be in a different cell cycle phase, and they might vary in size and RNA
content. The traditional RNA‐seq data analysis does not take transcriptional bimodality into
consideration, and implicitly assume the total RNA amount is the same or at least comparable.
Additionally, compared with bulk RNA‐seq, scRNA‐seq data have much larger technical
variations mainly because starting amount of RNA in a single cell is much lower and requires
many more cycles of amplification. Recently, Korthauer et al. [88] have developed scDD, a
differential analysis method particularly suited for scRNA‐seq, to characterize differences in
expression in the presence of distinct expression states within and among biological conditions.
Using simulated and case study data, they demonstrate that the modeling framework is able
to detect DE patterns of interest under a wide range of settings. Compared with existing
approaches, scDD has higher power to detect subtle differences in gene expression distribu‐
tions that are more complex than a mean shift, and is able to characterize those differences.
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6. Concluding remarks
In much the same way that the advent of NGS technologies transformed our approaches in
DNA‐sequencing, RNA‐seq approaches have dramatically changed our abilities to analyze the
transcriptome of cells and tissues with a new level of detail and sensitivity. But we must also
recognize that RNA‐seq analysis is vulnerable to the general biases and errors inherent to next‐
generation sequencing (NGS) technology upon which it is based.
While RNA‐seq technology is considered unbiased, it is important to note that the preparation
and fragmentation of RNA and the library construction (which includes size selection) can
introduce biases. Fragments are not uniformly sampled and sequenced, as there is variability
in sequencing depth across the transcriptome due to preferential sites of fragmentation,
variable primer, and tag nucleotide composition effects [89, 90]. RNA‐seq is a complicated
multistep process that involves sample collection and stabilization, RNA extraction, fragmen‐
tation, cDNA synthesis, adapter ligation, amplification, purification, and sequencing. Any step
in this complex sequence of protocols can result in biased data.
Data normalization is one of the most crucial steps of RNA‐seq data processing and has a
profound effect on the results of the analysis. In practice, normalization of high‐throughput
data still remains an important topic and has received a lot of attention in the literature. The
increasing number of normalization methods makes it difficult for scientists to decide which
method should be used for which particular data set [58–66]. Even worse, different research
groups draw contradictory conclusions. For example, Zyprych‐Walczak et al. [66] concluded
that the use of TMM method in most cases is displayed poorly, whereas the study by Dillies
et al. [64] indicated that the use of TMM method led to good performance on simulated RNA‐
seq data sets. Considering the confusion and the numbers of methods available, we believe
RNA‐seq data normalization is a fundamental question that is far from being solved, and RNA‐
seq community will have to develop more sophisticated and robust algorithms to tackle this
problem.
Additionally, for RNA‐seq data collected with multiple sequencing platforms or at multiple
sites, other normalization methods are required to remove site‐ or technology‐specific effects
[91]. Several methods for such normalization have been developed, including sva [92], RUV2
[93], and PEER [94], but they vary in their ability to remove these systematic biases [91]. As
the cost of NGS continues to decrease, it is likely that additional studies will be conducted to
readdress the same biological question. Therefore, there is an increasing need for analyzing
data from multiple studies and different labs [95].
In this chapter, we focused on data analysis workflow for mRNA‐seq, but have not covered
RNA‐seq experimental design. However, a crucial prerequisite for any successful RNA‐seq
study is a good experimental design, making sure the data generated have the potential to
answer the biological questions of interest. For other aspects of RNA‐seq data analysis,
including experimental design, alternative splicing, gene fusion, and eQTL mapping, please
refer to the most recent review by Conesa et al. [96]. In practice, RNA‐seq is not used as a stand‐
alone technology platform in research. The integration of RNA‐seq data with other types of
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genome‐wide data allows us to connect the regulation of gene expression with specific aspects
of molecular physiology and functional genomics. Integrative analyses that incorporate RNA‐
seq data with other genomic or proteomic experiments are becoming increasingly prevalent.
For instance, the combination of RNA and DNA sequencing can be used to explore RNA‐
editing or expression quantitative trait loci (eQTL) mapping. Pairwise DNA‐methylation and
RNA‐seq integration can reveal the correlation between gene expression and methylation
patterns. Additionally, integration of RNA‐seq and miRNA‐seq data has the potential to
unravel the regulatory effects of miRNAs on transcript steady‐state levels. All these integrative
analyses pose additional challenges that are beyond the scope of this chapter.
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